SynthesisJNCI cancer spectrum2025

Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis.

Francesco Schettini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.